.jpg "Health director-general Tan Sri Dr Noor Hisham Abdullah speaks during a press conference in Putrajaya December 2, 2020. — Picture by Shafwan Zaidon")
PUTRAJAYA, Dec 4 — Malaysia will soon embark on the third phase clinical trial for the one of its Covid-19 vaccine candidates, said Health director-general Tan Sri Dr Noor Hisham Abdullah today.
He said the trial will use the inactivated virus vaccine that was developed by China’s Institute of Medical Biology Chinese Academy of Medical Sciences in Beijing.
“We decided to carry out the trial following the first and second phase clinical trials, which indicated the vaccine is safe and produced good results,” Dr Noor Hisham said during his press conference.
MORE TO COME
